192 related articles for article (PubMed ID: 17289551)
1. The role of complement regulatory proteins (CD55 and CD59) in the pathogenesis of autoimmune hemocytopenias.
Ruiz-Argüelles A; Llorente L
Autoimmun Rev; 2007 Jan; 6(3):155-61. PubMed ID: 17289551
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities in the expression of CD55 and CD59 surface molecules on peripheral blood cells are not specific to paroxysmal nocturnal hemoglobinuria.
Ruiz-Delgado GJ; Vázquez-Garza E; Méndez-Ramírez N; Gómez-Almaguer D
Hematology; 2009 Feb; 14(1):33-7. PubMed ID: 19154662
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD55 and CD59 on peripheral blood cells from systemic lupus erythematosus (SLE) patients.
Alegretti AP; Mucenic T; Merzoni J; Faulhaber GA; Silla LM; Xavier RM
Cell Immunol; 2010; 265(2):127-32. PubMed ID: 20727519
[TBL] [Abstract][Full Text] [Related]
4. Expression levels of CD47, CD35, CD55, and CD59 on red blood cells and signal-regulatory protein-alpha,beta on monocytes from patients with warm autoimmune hemolytic anemia.
Barros MM; Yamamoto M; Figueiredo MS; Cançado R; Kimura EY; Langhi DM; Chiattone CS; Bordin JO
Transfusion; 2009 Jan; 49(1):154-60. PubMed ID: 18954403
[TBL] [Abstract][Full Text] [Related]
5. Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59.
Clayton A; Harris CL; Court J; Mason MD; Morgan BP
Eur J Immunol; 2003 Feb; 33(2):522-31. PubMed ID: 12645951
[TBL] [Abstract][Full Text] [Related]
6. Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59.
Ziller F; Macor P; Bulla R; Sblattero D; Marzari R; Tedesco F
Eur J Immunol; 2005 Jul; 35(7):2175-83. PubMed ID: 15971270
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of complement regulatory proteins, CD55 and CD59, on peripheral blood leucocytes in patients with type 2 diabetes and macrovascular diseases.
Ma XW; Chang ZW; Qin MZ; Sun Y; Huang HL; He Y
Chin Med J (Engl); 2009 Sep; 122(18):2123-8. PubMed ID: 19781296
[TBL] [Abstract][Full Text] [Related]
8. Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV).
Spear GT; Lurain NS; Parker CJ; Ghassemi M; Payne GH; Saifuddin M
J Immunol; 1995 Nov; 155(9):4376-81. PubMed ID: 7594597
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of different flow cytometry-based immunophenotypic methods for the analysis of CD59 and CD55 expression on major peripheral blood cell subsets.
Hernández-Campo PM; Martín-Ayuso M; Almeida J; López A; Orfao A
Cytometry; 2002 Jun; 50(3):191-201. PubMed ID: 12116342
[TBL] [Abstract][Full Text] [Related]
10. Reduced expression of CD55 and CD59 on peripheral blood cells from systemic lupus erythematosus: profitable to diagnose some complications?
Xu WD; Zhang YJ; Zhou M; Peng H; Liu SS; Ye DQ
Cell Immunol; 2011; 271(1):15. PubMed ID: 21802665
[No Abstract] [Full Text] [Related]
11. Diminished expression of complement regulatory proteins (CD55 and CD59) in lymphocytes from systemic lupus erythematosus patients with lymphopenia.
García-Valladares I; Atisha-Fregoso Y; Richaud-Patin Y; Jakez-Ocampo J; Soto-Vega E; Elías-López D; Carrillo-Maravilla E; Cabiedes J; Ruiz-Argüelles A; Llorente L
Lupus; 2006; 15(9):600-5. PubMed ID: 17080916
[TBL] [Abstract][Full Text] [Related]
12. Immunization against tumor cell surface complement-regulatory proteins.
Durrant LG; Spendlove I
Curr Opin Investig Drugs; 2001 Jul; 2(7):959-66. PubMed ID: 11757799
[TBL] [Abstract][Full Text] [Related]
13. Reduction of CD55 and/or CD59 in red blood cells of patients with HIV infection.
Terpos E; Sarantopoulos A; Kouramba A; Katsarou O; Stavropoulos J; Masouridi S; Karafoulidou A; Meletis J
Med Sci Monit; 2008 May; 14(5):CR276-280. PubMed ID: 18443552
[TBL] [Abstract][Full Text] [Related]
14. Co-expression of the complement regulatory proteins human DAF and CD59 with an IRES-mediated dicistronic mammalian vector enhances their cell protective effects.
Xu L; Shao H; Wu W; Cao Z; Zhao Z; Liu H; Jiang D; Mao X; Li W
Int J Mol Med; 2005 Sep; 16(3):409-14. PubMed ID: 16077947
[TBL] [Abstract][Full Text] [Related]
15. Cell-surface density of complement restriction factors (CD46, CD55, and CD59): oral squamous cell carcinoma versus other solid tumors.
Ravindranath NM; Shuler C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Feb; 103(2):231-9. PubMed ID: 17234541
[TBL] [Abstract][Full Text] [Related]
16. Complement regulatory proteins and autoimmunity.
Song WC
Autoimmunity; 2006 Aug; 39(5):403-10. PubMed ID: 16923540
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of red cell bound CD55 and CD59 in patients with systemic lupus erythematosus.
Richaud-Patin Y; Pérez-Romano B; Carrillo-Maravilla E; Rodriguez AB; Simon AJ; Cabiedes J; Jakez-Ocampo J; Llorente L; Ruiz-Argüelles A
Immunol Lett; 2003 Aug; 88(2):95-9. PubMed ID: 12880676
[TBL] [Abstract][Full Text] [Related]
18. Paroxysmal nocturnal hemoglobinuria: a complement-mediated hemolytic anemia.
DeZern AE; Brodsky RA
Hematol Oncol Clin North Am; 2015 Jun; 29(3):479-94. PubMed ID: 26043387
[TBL] [Abstract][Full Text] [Related]
19. Paroxysmal nocturnal hemoglobinuria.
Smith LJ
Clin Lab Sci; 2004; 17(3):172-7. PubMed ID: 15314892
[TBL] [Abstract][Full Text] [Related]
20. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.
Kumar S; Benseler SM; Kirby-Allen M; Silverman ED
Pediatrics; 2009 Jan; 123(1):e159-63. PubMed ID: 19074962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
